Operating Lease, Right-of-Use Asset in USD of GUIDED THERAPEUTICS INC from Q4 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
GUIDED THERAPEUTICS INC quarterly Operating Lease, Right-of-Use Asset history and change rate from Q4 2018 to Q3 2025.
  • GUIDED THERAPEUTICS INC Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $69K, a 57.9% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

GUIDED THERAPEUTICS INC Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $69K -$95K -57.9% 30 Sep 2025 10-Q 13 Nov 2025
Q2 2025 $94K -$91K -49.2% 30 Jun 2025 10-Q 14 Aug 2025
Q1 2025 $118K -$89K -43% 31 Mar 2025 10-Q 15 May 2025
Q4 2024 $141K -$86K -37.9% 31 Dec 2024 10-Q 13 Nov 2025
Q3 2024 $164K -$83K -33.6% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $185K -$81K -30.5% 30 Jun 2024 10-Q 14 Aug 2024
Q1 2024 $207K -$78K -27.4% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $227K -$76K -25.1% 31 Dec 2023 10-K 31 Mar 2025
Q3 2023 $247K -$74K -23.1% 30 Sep 2023 10-Q 13 Nov 2023
Q2 2023 $266K -$72K -21.3% 30 Jun 2023 10-Q 10 Aug 2023
Q1 2023 $285K -$70K -19.7% 31 Mar 2023 10-Q 15 May 2023
Q4 2022 $303K -$69K -18.5% 31 Dec 2022 10-K 28 Mar 2024
Q3 2022 $321K -$67K -17.3% 30 Sep 2022 10-Q 14 Nov 2022
Q2 2022 $338K -$65K -16.1% 30 Jun 2022 10-Q 15 Aug 2022
Q1 2022 $355K -$71K -16.7% 31 Mar 2022 10-Q 16 May 2022
Q4 2021 $372K -$81K -17.9% 31 Dec 2021 10-K 30 Mar 2023
Q3 2021 $388K +$327K +536% 30 Sep 2021 10-Q 15 Nov 2021
Q2 2021 $403K +$317K +369% 30 Jun 2021 10-Q 18 Aug 2021
Q1 2021 $426K +$317K +291% 31 Mar 2021 10-Q/A 18 Aug 2021
Q4 2020 $453K +$321K +243% 31 Dec 2020 10-K 30 Mar 2022
Q3 2020 $61K -$92K -60.1% 30 Sep 2020 10-Q/A 05 Nov 2020
Q2 2020 $86K -$89K -50.9% 30 Jun 2020 10-Q 20 Aug 2020
Q1 2020 $109K -$93K -46% 31 Mar 2020 10-Q 07 Jul 2020
Q4 2019 $132K +$132K 31 Dec 2019 10-K 07 Apr 2021
Q3 2019 $153K 30 Sep 2019 10-Q 09 Mar 2020
Q2 2019 $175K 30 Jun 2019 10-Q 11 Feb 2020
Q1 2019 $202K 31 Mar 2019 10-Q 11 Jul 2019
Q4 2018 $0 31 Dec 2018 10-K 20 Apr 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.